ASX:MMS McMillan Shakespeare (MMS) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About McMillan Shakespeare Stock (ASX:MMS) 30 days 90 days 365 days Advanced Chart Get McMillan Shakespeare alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume440,830 shsAverage VolumeN/AMarket CapitalizationA$952.72 millionP/E Ratio11.49Dividend Yield11.26%Price TargetN/AConsensus RatingN/A Company Overview McMillan Shakespeare Limited provides salary packaging, novated leasing, disability plan management and support co-ordination, asset management, and related financial products and services in Australia, the United Kingdom, and New Zealand. It operates through Group Remuneration Services, Asset Management Services, and Plan and Support Services segments. The Group Remuneration Services segment offers salary packaging and ancillary services, including novated leasing asset and finance procurement, motor vehicle administration, and other services. The Asset Management segment provides financing and ancillary management services related with motor vehicles, commercial vehicles, and equipment. The Plan and Support Services segment provides plan management and support coordination services to participants in the national disability insurance scheme. The company also provides asset management and services. It serves federal and state governments, public and private sectors, and health and charitable organizations. McMillan Shakespeare Limited founded in 1988 and is headquartered in Melbourne, Australia. Read More Receive MMS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for McMillan Shakespeare and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. MMS Stock News HeadlinesMcMillan Shakespeare Limited Announces Cessation of Securities2 hours ago | tipranks.comMcMillan Shakespeare Limited Announces Director’s Interest Changes2 hours ago | tipranks.comThe End of Elon Musk…?While headlines point to collapsing sales and fading tax credits, tech analyst Jeff Brown says Tesla is on the verge of its biggest breakthrough yet — a revolutionary form of “Manifested AI” that Forbes has called a multi-trillion-dollar opportunity, potentially sparking a 25,000% growth market and setting up what he believes could be the greatest corporate comeback in history.September 16 at 2:00 AM | Brownstone Research (Ad)McMillan Shakespeare Full Year 2025 Earnings: Beats ExpectationsSeptember 2, 2025 | finance.yahoo.comMcMillan Shakespeare (ASX:MMS) Has Announced A Dividend Of A$0.77August 31, 2025 | finance.yahoo.comMcMillan Shakespeare Releases 2025 Financial ResultsAugust 28, 2025 | tipranks.comMcMillan Shakespeare Limited Releases 2025 Governance DocumentsAugust 28, 2025 | tipranks.comInvestors in McMillan Shakespeare (ASX:MMS) have seen solid returns of 175% over the past five yearsAugust 5, 2025 | finance.yahoo.comSee More Headlines MMS Stock Analysis - Frequently Asked Questions How were McMillan Shakespeare's earnings last quarter? McMillan Shakespeare Limited (ASX:MMS) posted its quarterly earnings results on Wednesday, February, 20th. The company reported $0.42 earnings per share for the quarter. McMillan Shakespeare had a trailing twelve-month return on equity of 63.78% and a net margin of 16.37%. What other stocks do shareholders of McMillan Shakespeare own? Based on aggregate information from My MarketBeat watchlists, some other companies that McMillan Shakespeare investors own include Janus Henderson Group (HGG), Genesis Energy (GEL), G8 Education (GEM), 298755 (UGL.AX) (UGL), Reject Shop (TRS), Pilbara Minerals (PLS) and Magnetite Mines (MGT). Company Calendar Last Earnings2/20/2019Ex-Dividend for 9/25 Dividend9/10/2025Today9/15/2025Record date for 9/25 Dividend9/25/2025Dividend Payable9/25/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeASX SectorIndustrials Industry Staffing & Employment Services Sub-IndustryBusiness Services Current SymbolASX:MMS CIKN/A Webwww.mcms.com.au Phone+61-3-90973000FaxN/AEmployees39,500Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$1.28 Trailing P/E Ratio11.49 Forward P/E RatioN/A P/E Growth1.14Net IncomeA$90.06 million Net Margins16.37% Pretax MarginN/A Return on Equity63.78% Return on Assets8.34% Debt Debt-to-Equity Ratio456.47 Current Ratio1.18 Quick Ratio1.47 Sales & Book Value Annual SalesA$521.02 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow11.35 Book ValueA$1.84 per share Price / BookN/AMiscellaneous Outstanding Shares69,640,000Free FloatN/AMarket CapA$952.72 million OptionableNot Optionable Beta1.08 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free Report This page (ASX:MMS) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersNew Biotech Backed by Proven Incubator Now Open to PublicA successful biotech incubator just opened its next chapter - and you're invited to their raise. This deal ...i2i Marketing Group, LLC | Sponsored$3,600 gold is nice ... but here’s what most gold bugs are missingGold just surged past $3,600, but Weiss Ratings expert Sean Brodrick says the real upside is in select gold st...Weiss Ratings | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredDalio’s $319 Million Gold BetA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredIf you own dollars, read this...Former Goldman Exec: "A Strange Day Is Coming to America" Dr. David Eifrig, who warned of inflation months ...Stansberry Research | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding McMillan Shakespeare Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share McMillan Shakespeare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.